Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J
Intensive Care Units, Maisonneuve-Rosemont Hospital, Montreal, Canada.
Am J Kidney Dis. 1999 Sep;34(3):486-92. doi: 10.1016/s0272-6386(99)70076-4.
Clearances of several solutes (urea, creatinine, phosphate, urates, beta(2)-microglobulin [beta(2)-M]) were measured during venovenous continuous renal replacement therapy (CRRT) at various ultrafiltration (Q(UF); 0 to 2 L/h) and dialysate flow rates (Q(D); 0 to 2.5 L/h). Preset Multiflow-60 and Multiflow-100 hollow-fiber dialysers (M-60 and M-100; Hospal-Gambro, St-Leonard, Canada) were compared (five patients for each type). First, we evaluated the impact of predilution on convective clearances: a progressive decrease in patient clearances, similar for both filters, was observed, reaching a maximum of 15%, 18%, and 19% for urea, urates, and creatinine, respectively, with predilution at a Q(UF) of 2 L/h. Second, we compared convective and diffusive clearances. Because effluent to plasma ratio (E/P) remained at 1 for small solutes (urea, creatinine, phosphate, urates) during convection, clearances were equal to the effluent rate for both dialyzers. However, we observed greater diffusive clearances for small molecules with M-100 than with M-60 at a Q(D) of 1.5 to 2.5 L/h, the difference being more significant as molecular weight increased. For beta(2)-M, diffusive clearance was very low and rapidly reached a plateau of 8 and 12 mL/min for M-60 and M-100, respectively, at a Q(D) greater than 1.5 L/h. Convective clearances for beta(2)-M increased nonlinearly up to 20 +/- 2 mL/min at a progressively greater Q(UF) (from 0.5 to 2 L/h) for both M-60 and M-100. This nonlinear increase was attributed to an increase of almost 40% in E/P for beta(2)-M from a Q(UF) of 0.5 to 2 L/h. Third, the interaction between convection and diffusion was assessed by measuring solute clearances at a fixed Q(UF) (1 and 2 L/h) and variable Q(D) (0.5 to 2.5 L/h). For small molecules, no significant interaction between convection and diffusion was noticed with M-100, whereas only a small interaction was noticed with M-60. However, for beta(2)-M, the addition of diffusion (Q(D), 0.5 to 2.5 L/h) did not result in any significant increase in total clearances over convective clearances for M-60 and M-100. This observation suggests that the diffusive clearances for beta(2)-M observed with M-60 and M-100 at a Q(UF) of 0 L/h and at various Q(D) probably occurs by convective fluxes across the membrane. These results demonstrate that convection is more efficient than diffusion in removing mixed-molecular-weight solutes during CRRT.
在静脉 - 静脉连续性肾脏替代治疗(CRRT)期间,于不同超滤率(Q(UF);0至2L/h)和透析液流速(Q(D);0至2.5L/h)下,测量了几种溶质(尿素、肌酐、磷酸盐、尿酸盐、β2 - 微球蛋白[β2 - M])的清除率。比较了预设的Multiflow - 60和Multiflow - 100中空纤维透析器(M - 60和M - 100;加拿大圣莱昂纳德市Hospal - Gambro公司)(每种类型各5例患者)。首先,我们评估了预稀释对对流清除率的影响:观察到患者清除率逐渐下降,两种滤器情况相似,在Q(UF)为2L/h进行预稀释时,尿素、尿酸盐和肌酐的清除率分别最多下降15%、18%和19%。其次,我们比较了对流清除率和扩散清除率。由于在对流过程中小溶质(尿素、肌酐、磷酸盐、尿酸盐)的流出液与血浆比率(E/P)保持为1,两种透析器的清除率均等于流出液速率。然而,我们观察到在Q(D)为1.5至2.5L/h时,M - 100对小分子的扩散清除率高于M - 60,且随着分子量增加差异更显著。对于β2 - M,扩散清除率非常低,在Q(D)大于1.5L/h时,M - 60和M - 100的扩散清除率分别迅速达到8和12mL/min的平台值。对于M - 60和M - 100,随着Q(UF)逐渐增大(从0.5至2L/h),β2 - M的对流清除率非线性增加至20±2mL/min。这种非线性增加归因于β2 - M的E/P从Q(UF)为0.5L/h增加到2L/h时几乎增加了40%。第三,通过在固定Q(UF)(1和2L/h)和可变Q(D)(0.5至2.5L/h)下测量溶质清除率来评估对流与扩散之间的相互作用。对于小分子,M - 100未观察到对流与扩散之间有显著相互作用,而M - 60仅观察到轻微相互作用。然而,对于β2 - M,对于M - 60和M - 100,增加扩散(Q(D)为0.5至2.5L/h)并未导致总清除率相对于对流清除率有任何显著增加。这一观察结果表明,在Q(UF)为0L/h和不同Q(D)时,M - 60和M - 100观察到的β2 - M的扩散清除率可能是通过跨膜对流通量发生的。这些结果表明,在CRRT期间,对流在清除混合分子量溶质方面比扩散更有效。